Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Nong-hua Lu"'
Autor:
Ren-Chun Du, Xing Liu, Yong-Kang Lai, Yu-Xin Hu, Hao Deng, Hui-Qiao Zhou, Nong-Hua Lu, Yin Zhu, Yi Hu
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/87e5ae9d23154b02b04eb2fe4d160ffe
Autor:
Xiao-Ting Jiang, Ling Ding, Xin Huang, Yu-Peng Lei, Hua-Jing Ke, Hui-Fang Xiong, Ling-Yu Luo, Wen-Hua He, Liang Xia, Nong-Hua Lu, Yin Zhu
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
AimCardiac injury, reflected by the measured concentrations of chemicals released from injured cardiac muscle, is common in acute pancreatitis (AP). However, there is no adequate evidence assessing the impact of cardiac injury on AP-related outcomes.
Externí odkaz:
https://doaj.org/article/339f9d9d787b47ed92b25798a2f3c46e
Autor:
Wenjun Liu, Nong-Hua Lu, Xu Zhou, Yingmeng Li, Yong Xie, Longjin Zheng, Weifeng Zhu, Qiuping Xiao, Ni Yang, Kexuan Zuo, Tielong Xu, Heping Zhang
Publikováno v:
Contemporary Clinical Trials Communications, Vol 32, Iss , Pp 101085- (2023)
Background: Probiotics may be an ideal choice for these patients, given it can improve the defecation and quality of life of individuals with chronic diarrhoea. However, evidence-based medical research is still limited to support its use as a diarrho
Externí odkaz:
https://doaj.org/article/fb135b9b4fef4395be3d2a67bde463ea
Autor:
Wenjun Liu, Yong Xie, Yingmeng Li, Longjin Zheng, Qiuping Xiao, Xu Zhou, Qiong Li, Ni Yang, Kexuan Zuo, Tielong Xu, Nong-Hua Lu, Heping Zhang
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background For patients with gastro-oesophageal reflux symptoms, the preferred treatment is proton pump inhibitor (PPI) administration for approximately 8 weeks. However, long-term use of PPIs can cause gut microbiome (GM) disturbances. This
Externí odkaz:
https://doaj.org/article/a4b9a84d1a704061b0be6e32ed7cabc7
Autor:
Yi Hu, Xin Xu, Xiao-Shun Liu, Cong He, Yao-Bin Ouyang, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Yong Xie, Xu Shu, Yin Zhu, David Y. Graham, Nong-Hua Lu
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Background and aimWe previously reported that vonoprazan-amoxicillin (VA) dual therapy for 7 or 10 days is not satisfactorily efficacious for Helicobacter pylori (H. pylori) eradication. We aimed to explore the efficacy of VA dual therapy for 14 days
Externí odkaz:
https://doaj.org/article/7d7d656c4e1c431e847bca9220cb56f6
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Helicobacter pylori (H. pylori) infection, a type-1 carcinogen, was closely associated with gastric cancer (GC). Successfully eradicating H. pylori infection could reduce the incidence of GC. China was a country with high incidence of GC and high pre
Externí odkaz:
https://doaj.org/article/bb8d0fb796e147a4abe340e1704b3b62
Autor:
Yi Hu, Xin Xu, Yao-Bin Ouyang, Cong He, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Xu Shu, Yong Xie, Nong-Hua Lu, Yin Zhu
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
The combination of vonoprazan (VPZ) and amoxicillin (VA therapy) has been shown to achieve acceptable eradication rates for Helicobacter pylori (H. pylori). Herein, our aim was to explore the short-term effect of VA therapy on the gut microbiota and
Externí odkaz:
https://doaj.org/article/b7f638c534534ef89b5364dc39325bc9
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 3, Pp 335-343 (2020)
Abstract. The main challenge in the field of Helicobacter pylori (H. pylori) infection is antibiotic resistance, which influences the efficacy of eradication regimens. Bismuth-containing quadruple therapy has been confirmed as an effective regimen fo
Externí odkaz:
https://doaj.org/article/8f2f8c498190468b96b9aa28580e3d67
Autor:
Dong-sheng Liu, You-hua Wang, Zhen-hua Zhu, Shuang-hong Zhang, Xuan Zhu, Jian-hua Wan, Nong-hua Lu, Yong Xie
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-7 (2019)
Abstract Aims To describe the characteristics of Helicobacter pylori (H. pylori) antibiotic resistance in clinical isolates from four populations. Methods In total, 1463 H. pylori strains were examined for antibiotic resistance. Among these strains,
Externí odkaz:
https://doaj.org/article/59ada6da2d90483ea5aa278bc3929ef9
Publikováno v:
Gut Microbes, Vol 12, Iss 1 (2020)
Helicobacter pylori (H. pylori), a common pathogenic bacterium in the stomach, has been demonstrated to be a major cause of gastric cancer (GC). The typical pathological evolution of H. pylori infection-induced GC involves development from gastric at
Externí odkaz:
https://doaj.org/article/ff54d14b6004466693c49b2d80912fc6